Hana Pharm Co., Ltd. (KRX:293480)
South Korea · Delayed Price · Currency is KRW 9,150.00
-170.00 (-1.82%)
Last updated: Apr 2, 2026, 2:33 PM KST
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 163.51 billion as of April 2, 2026. Its market cap has decreased by -11.54% in one year.
Market Cap
163.51B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
4.10
Stock Price
9,150.00
Market Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 163.51B, a decrease of -69.55%. That is a compound annual growth rate of -14.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 163.51B | -18.00% |
| Dec 30, 2025 | 199.41B | 2.94% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 200.94B |
| JW Lifescience | 199.91B |
| Samil Pharmaceutical Co.,Ltd | 195.31B |
| Whan In Pharm | 194.64B |
| AptaBio Therapeutics | 193.84B |
| REYON Pharmaceutical | 184.14B |
| Kyongbo Pharmaceutical | 182.65B |
| Daihan Pharmaceutical | 171.11B |